Bowel cancer is a commonly diagnosed cancer in Australia. If detected early, it can often be treated successfully. But if the cancer has spread to the peritoneum – a membrane that covers the organs in the abdomen – treatment options are limited and the survival rate is poor.
Our researchers are seeking to improve our understanding of this cancer by investigating its molecular structure and behaviour, with the aim of finding better treatments.
“We are testing tissue samples with different drugs to look at the proteins, molecules and structure around the cell, to see how they react,” says Dr Kate Mahon, Deputy Director of Medical Oncology. “For metastatic peritoneal cancer, there is no real research on this at the moment.”
Chris O’Brien Lifehouse is uniquely placed to conduct this research as one of the few hospitals in the state with a specialist peritonectomy unit – a centre of surgeons specially trained to operate on peritoneal cancer. We are excited to be partnering with the well-established peritonectomy unit at The Christie hospital in Manchester, UK, and hope to form partnerships with other peritonectomy units around Australia.
Your support has enabled us to employ a research officer to collect and transfer tissue samples and assist the research through every stage of this study